SKOUT system

The SKOUT system is a software-based computer-aided detection (CADe) system designed by Iterative Health to assist gastroenterologists in real-time identification of colorectal polyps during white light colonoscopy. Through robust non-clinical performance testing, including software verification, validation, and algorithm performance, the system has demonstrated substantial equivalence to predicate devices, confirming its safety and effectiveness for clinical use in colorectal cancer screening and surveillance.

The SKOUT system, developed by Iterative Health, has been deemed substantially equivalent to existing legally marketed predicate devices, enabling its market entry. This software-based computer-aided detection (CADe) system is engineered to provide real-time assistance to qualified gastroenterologists during white light colonoscopy examinations, specifically for identifying potential colorectal polyps. It functions by displaying a visual aid, such as a blue rectangular outline, on the endoscopic monitor to highlight suspicious areas and includes a device status indicator. The system is exclusively intended for adult patients undergoing colorectal cancer screening or surveillance procedures, serving as an auxiliary tool that does not replace the clinician's medical judgment or act as a primary diagnostic instrument. Its market clearance is contingent upon adherence to various ongoing regulatory provisions, including annual registration, device listing, good manufacturing practices, proper labeling, and compliance with the Unique Device Identification System (UDI Rule) and Quality System regulation, which covers design controls and corrective actions. Non-clinical performance testing, encompassing electrical safety, usability, electromagnetic compatibility, software verification and validation, and algorithm performance, was rigorously conducted to affirm the device's safety and effectiveness. These tests confirmed its equivalence to predicate devices, despite minor updates to its hardware and software components, ensuring its readiness for clinical application.

AI Regulatory Concerns

Powered by

Jev reads the full FDA letter and returns calibrated concern probabilities per regulatory category. These are AI estimates, not regulatory advice.

• Q1. How does the SKOUT system's real-time detection performance compare to traditional colonoscopy without CADe assistance in terms of polyp detection rate and false positive rate?; What specific types of polyps (e.g., flat, serrated, diminutive) is the SKOUT system most effective at detecting, and are there any types it tends to miss?; What is the learning curve for gastroenterologists to effectively integrate the SKOUT system into their practice, and how does it impact procedure time?; Beyond the non-clinical performance testing, what clinical trial data, if any, supports the long-term efficacy and impact on patient outcomes (e.g., interval cancer rates) of using the SKOUT system?; How does the SKOUT system account for variations in endoscopic image quality, and what are its limitations in challenging anatomical or preparation conditions?